PPARGC1A and hepatocellular carcinoma: However, although PGC1β protein was identified to hold the similar mechanisms in sorafenib-resistant hepatocellular carcinoma cells [32], it was not found in NSCLC spheres, which means the cell-specific character of PGC1α/β ubiquitination.